PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 12810350-6 2003 Annexin V-fluorescein isothiocyanate (FITC)-propidium iodide (PI) apoptosis flow cytometric assay showed that early apoptotic CD4(+) T cells (annexin V-FITC(+)PI(-)), but not late apoptotic CD4(+) T cells (annexin V-FITC(+)PI(+)), increased in the inflamed skin of mice with CH. Fluorescein-5-isothiocyanate 38-42 CD4 antigen Mus musculus 126-129 26902275-8 2016 FITC-labeled human anti-mouse CD4 monoclonal antibody and PE-labeled human anti-mouse interleukin-4 (IL-4) monoclonal antibody were added to the other part of cell suspension to mark Th2. Fluorescein-5-isothiocyanate 0-4 CD4 antigen Mus musculus 30-33 24618260-7 2014 CD4+ and CD8+ T cells subtypes were detected by flow cytometry with FITC-labelled antimouse CD4 and PE antimouse CD8 staining. Fluorescein-5-isothiocyanate 68-72 CD4 antigen Mus musculus 0-3 23884312-5 2014 A significant increase of CD4+ CD25+-activated T cells (P<0.01) and elevated serum IgE levels (P<0.05) in KO mice indicated more the development of FITC sensitization than an irritative reaction. Fluorescein-5-isothiocyanate 154-158 CD4 antigen Mus musculus 26-29 15096484-0 2004 Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse. Fluorescein-5-isothiocyanate 105-131 CD4 antigen Mus musculus 37-40 15096484-10 2004 These findings indicate a contribution of MHC II-independent CD4(+) T cells and/or CD4(+) NKT cells to the Th2 response triggered by FITC in vivo, and makes FITC-induced CHS a suitable animal model for atopic dermatitis. Fluorescein-5-isothiocyanate 133-137 CD4 antigen Mus musculus 61-64 15096484-10 2004 These findings indicate a contribution of MHC II-independent CD4(+) T cells and/or CD4(+) NKT cells to the Th2 response triggered by FITC in vivo, and makes FITC-induced CHS a suitable animal model for atopic dermatitis. Fluorescein-5-isothiocyanate 133-137 CD4 antigen Mus musculus 83-86 15096484-10 2004 These findings indicate a contribution of MHC II-independent CD4(+) T cells and/or CD4(+) NKT cells to the Th2 response triggered by FITC in vivo, and makes FITC-induced CHS a suitable animal model for atopic dermatitis. Fluorescein-5-isothiocyanate 157-161 CD4 antigen Mus musculus 61-64 15096484-10 2004 These findings indicate a contribution of MHC II-independent CD4(+) T cells and/or CD4(+) NKT cells to the Th2 response triggered by FITC in vivo, and makes FITC-induced CHS a suitable animal model for atopic dermatitis. Fluorescein-5-isothiocyanate 157-161 CD4 antigen Mus musculus 83-86 9686595-5 1998 Cell lines and clones established from unirradiated and UV-irradiated, FITC-sensitized mice were CD4+, CD8-, TCR-alpha/beta+, MHC restricted, and hapten specific. Fluorescein-5-isothiocyanate 71-75 CD4 antigen Mus musculus 97-100 11745142-6 2001 Each indirect labeling scheme incorporated a primary mouse anti-CD4 FITC antibody that provides both FITC and mouse-specific binding sites for two different secondary antibody-magnetic nanoparticle conjugates: either anti-FITC MACS magnetic nanoparticle antibody or anti-mouse MACS magnetic nanoparticle antibody. Fluorescein-5-isothiocyanate 68-72 CD4 antigen Mus musculus 64-67 11745142-6 2001 Each indirect labeling scheme incorporated a primary mouse anti-CD4 FITC antibody that provides both FITC and mouse-specific binding sites for two different secondary antibody-magnetic nanoparticle conjugates: either anti-FITC MACS magnetic nanoparticle antibody or anti-mouse MACS magnetic nanoparticle antibody. Fluorescein-5-isothiocyanate 101-105 CD4 antigen Mus musculus 64-67 11745142-6 2001 Each indirect labeling scheme incorporated a primary mouse anti-CD4 FITC antibody that provides both FITC and mouse-specific binding sites for two different secondary antibody-magnetic nanoparticle conjugates: either anti-FITC MACS magnetic nanoparticle antibody or anti-mouse MACS magnetic nanoparticle antibody. Fluorescein-5-isothiocyanate 101-105 CD4 antigen Mus musculus 64-67 11745142-8 2001 The results indicate that an average of 3.4 anti-FITC MACS magnetic nanoparticle antibodies bind to each primary CD4 FITC antibody, Psi(1,2f) = 3.4 +/- 0.33, and that approximately one, Psi(1,2m) = 0.98 +/- 0.081, anti-mouse MACS magnetic nanoparticle antibody binds to each primary mouse CD4 FITC antibody on a CD4 positive lymphocyte. Fluorescein-5-isothiocyanate 49-53 CD4 antigen Mus musculus 113-116 11745142-8 2001 The results indicate that an average of 3.4 anti-FITC MACS magnetic nanoparticle antibodies bind to each primary CD4 FITC antibody, Psi(1,2f) = 3.4 +/- 0.33, and that approximately one, Psi(1,2m) = 0.98 +/- 0.081, anti-mouse MACS magnetic nanoparticle antibody binds to each primary mouse CD4 FITC antibody on a CD4 positive lymphocyte. Fluorescein-5-isothiocyanate 49-53 CD4 antigen Mus musculus 289-292 11745142-8 2001 The results indicate that an average of 3.4 anti-FITC MACS magnetic nanoparticle antibodies bind to each primary CD4 FITC antibody, Psi(1,2f) = 3.4 +/- 0.33, and that approximately one, Psi(1,2m) = 0.98 +/- 0.081, anti-mouse MACS magnetic nanoparticle antibody binds to each primary mouse CD4 FITC antibody on a CD4 positive lymphocyte. Fluorescein-5-isothiocyanate 49-53 CD4 antigen Mus musculus 289-292 11745142-8 2001 The results indicate that an average of 3.4 anti-FITC MACS magnetic nanoparticle antibodies bind to each primary CD4 FITC antibody, Psi(1,2f) = 3.4 +/- 0.33, and that approximately one, Psi(1,2m) = 0.98 +/- 0.081, anti-mouse MACS magnetic nanoparticle antibody binds to each primary mouse CD4 FITC antibody on a CD4 positive lymphocyte. Fluorescein-5-isothiocyanate 117-121 CD4 antigen Mus musculus 113-116 11745142-8 2001 The results indicate that an average of 3.4 anti-FITC MACS magnetic nanoparticle antibodies bind to each primary CD4 FITC antibody, Psi(1,2f) = 3.4 +/- 0.33, and that approximately one, Psi(1,2m) = 0.98 +/- 0.081, anti-mouse MACS magnetic nanoparticle antibody binds to each primary mouse CD4 FITC antibody on a CD4 positive lymphocyte. Fluorescein-5-isothiocyanate 117-121 CD4 antigen Mus musculus 289-292 11745142-8 2001 The results indicate that an average of 3.4 anti-FITC MACS magnetic nanoparticle antibodies bind to each primary CD4 FITC antibody, Psi(1,2f) = 3.4 +/- 0.33, and that approximately one, Psi(1,2m) = 0.98 +/- 0.081, anti-mouse MACS magnetic nanoparticle antibody binds to each primary mouse CD4 FITC antibody on a CD4 positive lymphocyte. Fluorescein-5-isothiocyanate 117-121 CD4 antigen Mus musculus 289-292 11745142-8 2001 The results indicate that an average of 3.4 anti-FITC MACS magnetic nanoparticle antibodies bind to each primary CD4 FITC antibody, Psi(1,2f) = 3.4 +/- 0.33, and that approximately one, Psi(1,2m) = 0.98 +/- 0.081, anti-mouse MACS magnetic nanoparticle antibody binds to each primary mouse CD4 FITC antibody on a CD4 positive lymphocyte. Fluorescein-5-isothiocyanate 117-121 CD4 antigen Mus musculus 113-116 11745142-8 2001 The results indicate that an average of 3.4 anti-FITC MACS magnetic nanoparticle antibodies bind to each primary CD4 FITC antibody, Psi(1,2f) = 3.4 +/- 0.33, and that approximately one, Psi(1,2m) = 0.98 +/- 0.081, anti-mouse MACS magnetic nanoparticle antibody binds to each primary mouse CD4 FITC antibody on a CD4 positive lymphocyte. Fluorescein-5-isothiocyanate 117-121 CD4 antigen Mus musculus 289-292 11745142-8 2001 The results indicate that an average of 3.4 anti-FITC MACS magnetic nanoparticle antibodies bind to each primary CD4 FITC antibody, Psi(1,2f) = 3.4 +/- 0.33, and that approximately one, Psi(1,2m) = 0.98 +/- 0.081, anti-mouse MACS magnetic nanoparticle antibody binds to each primary mouse CD4 FITC antibody on a CD4 positive lymphocyte. Fluorescein-5-isothiocyanate 117-121 CD4 antigen Mus musculus 289-292 11122447-0 2000 Role of CD4(+) T helper 2-type cells in cutaneous inflammatory responses induced by fluorescein isothiocyanate. Fluorescein-5-isothiocyanate 84-110 CD4 antigen Mus musculus 8-11 11122447-4 2000 A biphasic pattern of cutaneous inflammatory reactions was elicited by exposure to FITC, the early phase of which could be transferred passively with serum (presumably immunoglobulin E [IgE] antibody), whereas adoptive transfer experiments demonstrated that Th2-type CD4(+) cells were responsible for the delayed-type component of the dermal hypersensitivity reaction. Fluorescein-5-isothiocyanate 83-87 CD4 antigen Mus musculus 267-270 2147072-6 1990 Altered thymic production of CD4 and CD8 cells could be excluded by intrathymic injection of FITC (fluorescein isothiocyanate). Fluorescein-5-isothiocyanate 99-125 CD4 antigen Mus musculus 29-32 8632053-2 1996 Labelling thymocytes in situ with fluorescein isothiocyanate (FITC) we note that the export of immature cells, CD4+CD8+, double positive (DP), and double negative, CD4-CD8- (DN), from the thymus was consistently increased 24 and 48 h after vagotomy. Fluorescein-5-isothiocyanate 34-60 CD4 antigen Mus musculus 164-171 8632053-2 1996 Labelling thymocytes in situ with fluorescein isothiocyanate (FITC) we note that the export of immature cells, CD4+CD8+, double positive (DP), and double negative, CD4-CD8- (DN), from the thymus was consistently increased 24 and 48 h after vagotomy. Fluorescein-5-isothiocyanate 62-66 CD4 antigen Mus musculus 111-114 8632053-2 1996 Labelling thymocytes in situ with fluorescein isothiocyanate (FITC) we note that the export of immature cells, CD4+CD8+, double positive (DP), and double negative, CD4-CD8- (DN), from the thymus was consistently increased 24 and 48 h after vagotomy. Fluorescein-5-isothiocyanate 62-66 CD4 antigen Mus musculus 164-171 2456858-2 1988 A new B220+ L3T4+ phenotype was demonstrated in T-cell populations of these mice by two-color flow cytometry with phycoerythrin-conjugated monoclonal antibodies (MoAb) to L3T4 and FITC-anti-B220 MoAb. Fluorescein-5-isothiocyanate 180-184 CD4 antigen Mus musculus 12-16 32615414-6 2020 It triggered IL-10 production and allowed the endocytosis of FITC-coupled antigens followed by their presentation to CD4+ T cells. Fluorescein-5-isothiocyanate 61-65 CD4 antigen Mus musculus 117-120